Catalyst
Slingshot members are tracking this event:
Top-Line Phase 2 CARRIE Data Evaluating MM-141 in Front Line Pancreatic Cancer Due H2 2018 - Discontinued
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MACK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 25, 2018
Occurred Source:
http://investors.merrimack.com/news-releases/news-release-details/merrimack-announces-top-line-results-randomized-phase-2-trial-mm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2 Data, Mm-141, Pancreatic Cancer, Discontinued, Discontinuation
